These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 11886176

  • 1. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X, Cress WD, Zhong Q, Zuckerman KS.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):930-9. PubMed ID: 11027571
    [Abstract] [Full Text] [Related]

  • 4. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB, Branton PE.
    Oncogene; 1997 Aug 07; 15(6):657-68. PubMed ID: 9264406
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
    Lind EF, Wayne J, Wang QZ, Staeva T, Stolzer A, Petrie HT.
    J Immunol; 1999 May 01; 162(9):5374-9. PubMed ID: 10228014
    [Abstract] [Full Text] [Related]

  • 6. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K, Vlach J, Hennecke S, Amati B.
    EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992
    [Abstract] [Full Text] [Related]

  • 7. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA.
    Crit Rev Biochem Mol Biol; 1996 Jun 01; 31(3):237-71. PubMed ID: 8817077
    [Abstract] [Full Text] [Related]

  • 8. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM, Gao CY, Chauthaiwale VM, Zelenka PS.
    Oncogene; 1998 Jan 22; 16(3):399-408. PubMed ID: 9467965
    [Abstract] [Full Text] [Related]

  • 9. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L, Polanowska J, Fabbrizio E, Olivier M, Philips A, Ng Eaton E, Classon M, Geng Y, Sardet C.
    EMBO J; 1999 Apr 01; 18(7):1878-90. PubMed ID: 10202151
    [Abstract] [Full Text] [Related]

  • 10. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ, Schaley JE, Feeney G, Hearing P.
    Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936
    [Abstract] [Full Text] [Related]

  • 11. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM, Caputi M, Khalili K, Giordano A.
    Cancer Res; 2000 May 15; 60(10):2737-44. PubMed ID: 10825149
    [Abstract] [Full Text] [Related]

  • 12. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K, Nakajima Y, Eto K, Ikeda MA.
    Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826
    [Abstract] [Full Text] [Related]

  • 13. Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.
    Mori A, Higashi H, Hoshikawa Y, Imamura M, Asaka M, Hatakeyama M.
    Oncogene; 1999 Nov 04; 18(46):6209-21. PubMed ID: 10597219
    [Abstract] [Full Text] [Related]

  • 14. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA.
    Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091
    [Abstract] [Full Text] [Related]

  • 15. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P, De Luca A, Bagella L, Giordano A.
    Cancer Res; 1998 Nov 15; 58(22):5049-52. PubMed ID: 9823308
    [Abstract] [Full Text] [Related]

  • 16. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD, Farlie PG, Watson RJ.
    Oncogene; 1996 Sep 05; 13(5):1073-82. PubMed ID: 8806697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G, Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A, Paggi MG.
    J Cell Biochem; 1997 Dec 01; 67(3):297-303. PubMed ID: 9361185
    [Abstract] [Full Text] [Related]

  • 19. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
    Smith EJ, Leone G, Nevins JR.
    Cell Growth Differ; 1998 Apr 01; 9(4):297-303. PubMed ID: 9563849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.